GL1X · GenesisL1 explorer

MolNFT v1 · #123588 · protein

FCHO1 mu homology domain (danio rerio) with bound EPS15 peptide

5JP2 · Epidermal growth factor receptor substrate 15: “FCHO1 mu homology domain (danio rerio) with bound EPS15 peptide”. X-ray diffraction, 1 ligand (ZN), 1 pocket (best druggability 0.73). MolNFT v1 #123588 on GenesisL1: 3D structure…

PDB
5JP2
Type
protein
Length
578 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor substrate 15; F-bar domain only protein 1
UniProt
P42566, A0A0R4IJ14
Ligands
ZN
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 3 distinct chains · 10% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
E, FEpidermal growth factor receptor substrate 15protein180% helix, 0% strandP42566
AF-bar domain only protein 1protein27210% helix, 53% strandA0A0R4IJ14
BF-bar domain only protein 1protein27010% helix, 54% strandA0A0R4IJ14

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19540.730.7799empty

Interfaces

3 interfaces between chains.

  • E–A · 850 Ų buried · 10 hydrogen bonds · protein-protein
  • F–B · 841 Ų buried · 10 hydrogen bonds · protein-protein
  • A–B · 464 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 5JP2 · Fcho1 Mu homology domain (Danio Rerio) with bound Eps15 peptide · the same entry in another collection · chain E against E, TM-score 1.00
  • P42566 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor substrate 15… · a predicted model of the same protein · chain F against A, TM-score 0.22

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.